Frontlight ResearchEarly access
Taking people in GermanyPhase 1
Naronapride at different doses in people with gastroparesis and healthy volunteers
Tests naronapride doses in people with gastroparesis and healthy volunteers.
Key facts
- Who runs it
- Dr. Falk Pharma GmbH
- Where
- Erfurt, GermanySee the siteAlso in 2 other countries, 2 sites
- Trial code
- Registry title
- A phase 1 multi-centre, randomized, single-blind, steady-state study to evaluate pharmacokinetics, pharmacodynamics, safety and tolerability after multiple-dose administration of three different doses of naronapride in patients with moderate idiopathic or diabetic gastroparesis compared to healthy subjects
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 60 people, planned
- Started
- 16 Jul 2025
- Expected to end
- 30 Nov 2026
- Type of study
- Interventional
- Record updated
- 24 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with moderate idiopathic or diabetic gastroparesis, and healthy volunteers for comparison. Gastroparesis means the stomach empties too slowly. The trial studies three doses of naronapride.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Moderate gastroparesis, either idiopathic (no known cause) or caused by diabetes. Healthy volunteers can also join.
Where in Germany
Also in 2 other countries, 2 sites
- SocraTec R&D Concepts in Drug Research and Development GmbHErfurt, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Naronapride at different doses in people with gastroparesis and healthy volunteersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 24 March 2026